SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-140630
Filing Date
2021-04-29
Accepted
2021-04-29 16:40:59
Documents
5
Period of Report
2021-06-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d170327ddef14a.htm DEF 14A 376821
2 GRAPHIC g170327g02a02.jpg GRAPHIC 37943
3 GRAPHIC g170327g38c45.jpg GRAPHIC 182902
4 GRAPHIC g170327g40d35.jpg GRAPHIC 164285
5 GRAPHIC g170327g94e33.jpg GRAPHIC 45303
  Complete submission text file 0001193125-21-140630.txt   961825
Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39856 | Film No.: 21871419
SIC: 2836 Biological Products, (No Diagnostic Substances)